GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (OTCPK:MDBIF) » Definitions » Total Payout Ratio

MDBIF (TrivarX) Total Payout Ratio : 8.92 (As of May. 04, 2025)


View and export this data going back to 2017. Start your Free Trial

What is TrivarX Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

TrivarX's current Total Payout Ratio is 8.92.


TrivarX Total Payout Ratio Historical Data

The historical data trend for TrivarX's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TrivarX Total Payout Ratio Chart

TrivarX Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 3.35 0.27 0.80 3.60

TrivarX Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.85 0.64 2.73 9.78 7.41

Competitive Comparison of TrivarX's Total Payout Ratio

For the Health Information Services subindustry, TrivarX's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TrivarX's Total Payout Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where TrivarX's Total Payout Ratio falls into.


;
;

TrivarX Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

TrivarX's Total Payout Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 2.956 + 0) / -0.821
=3.60

TrivarX's Total Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0.03 + 0.46 + 0) / -0.058
=7.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TrivarX Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of TrivarX's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TrivarX Business Description

Traded in Other Exchanges
Address
647 Beaufort Street, Mount Lawley, WA, AUS, 6050
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

TrivarX Headlines

From GuruFocus

Peer-reviewed Neurology Publication on Medibio Science

By Marketwired Marketwired 06-27-2018

Medibio Receives TGA Approval

By Marketwired Marketwired 06-19-2018

Medibio Named Finalist for Prestigious Optus My Business Award

By Marketwired Marketwired 10-01-2018

Medibio Provides Market Update

By Marketwired Marketwired 09-10-2018

Departure of Managing Director & Chief Executive Officer

By Marketwired Marketwired 08-29-2018

Medibio Launches Global Corporate Mental Health Product

By Marketwired Marketwired 05-01-2018

Medibio finalizes acquisition of Vital Conversations

By Marketwired Marketwired 04-12-2018

Medibio Announces Executive Leadership Changes

By Marketwired Marketwired 09-21-2018